At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 20 enrolled
Drug / intervention
Lidocaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Systemic Intraoperative Lidocaine Infusion for Postoperative Pain Management in Obese Patients: A Randomized, Placebo-Controlled Pilot Study
In Brief
A Phase 3 clinical trial evaluating Lidocaine and Placebo for Bariatric Surgical Pain. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The primary objective is to assess the feasibility and safety of administering continuous intraoperative lidocaine infusions in adult patients undergoing laparoscopic Roux en Y Gastric Bypass (RYGB). The secondary objective is to determine if lidocaine administration versus placebo (dextrose administration) (initiated at the time of anesthesia induction and continued until extubation) will reduce postoperative narcotic requirements.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBariatric Surgical Pain
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartAug 2013
First PostedSep 2013
Primary CompletionJul 2014
Study CompletionSep 2014
TodayJul 2026
First PostedSep 17, 2013
Enrollment StartAug 1, 2013
Primary CompletionJul 1, 2014
Study CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 12.8 years ago
Interventions
Lidocainedrug
Placebodrug